A Phase II Trial of Cetuximab and Docetaxel With Radiation for Head and Neck Cancer
Published: | Updated:
The use of low-dose radiotherapy may offer transient benefits; nonetheless the potential for palliative care exists.
Vivek N. Patel, MD
Articles by Vivek N. Patel, MD
Latest Updated Articles
A Phase II Trial of Cetuximab and Docetaxel With Radiation for Head and Neck CancerPublished: April 20th 2017 | Updated: April 18th 2020